Patent · US Active

Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease

US9675649B2 · kind B2 · utility

2Cited by
1References
5Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 3, 2012
Grant dateJun 13, 2017
Priority date—
Expiry dateFeb 3, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7095
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides formulations comprising isolated Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.